Development and validation of a novel reporter gene assay for determination of recombinant human thrombopoietin.
Sign Up to like & getrecommendations! Published in 2021 at "International immunopharmacology"
DOI: 10.1016/j.intimp.2021.107982
Abstract: Recombinant human thrombopoietin (rhTPO) was approved by the National Medical Products Administration in 2010 for the treatment of thrombocytopenia in patients with immune thrombocytopenic purpura and chemotherapy-induced thrombocytopenia. Nevertheless, no method for determining rhTPO bioactivity… read more here.
Keywords: reporter; recombinant human; gene assay; reporter gene ... See more keywords